Effects of electronegative VLDL on endothelium damage in metabolic syndrome

Diabetes Care

Volumn 35, Issue 3, 2012, Pages 648-653

  Chen, Chu Huang ^a,b,c,d   Lu, Jonathan ^a   Chen, Shu Hua ^a   Huang, Roger Y ^a   Yilmaz, H Ramazan ^a,e   Dong, Jianwen ^a   Elayda, Macarthur A ^a   Dixon, Richard A F ^a   Yang, Chao Yuh ^a,b,c,d  

^a TEXAS HEART INSTITUTE   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

^d CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^e MEVLANA UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B100; APOLIPOPROTEIN C; CHOLESTEROL; GLUCOSE; REACTIVE OXYGEN METABOLITE; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ADULT; ANION EXCHANGE CHROMATOGRAPHY; AORTA; APOPTOSIS; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DIET RESTRICTION; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; FEMALE; GLUCOSE BLOOD LEVEL; HIGH RISK POPULATION; HUMAN; HUMAN CELL; LIPOPROTEIN BLOOD LEVEL; MALE; METABOLIC SYNDROME X; OXIDATIVE STRESS; PROTEIN BLOOD LEVEL; SURFACE CHARGE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

ADULT; CHOLESTEROL, VLDL; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; LINEAR MODELS; MALE; METABOLIC SYNDROME X; MIDDLE AGED;

EID: 84859045499     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc11-1623     Document Type: Article

References (24)

1. Krauss RM. Lipids and lipoproteins inpatients with type 2 diabetes. Diabetes Care 2004;27:1496-1504 (Pubitemid 38680002)
2. Liao Y, Kwon S, Shaughnessy S, et al. Critical evaluation of adult treatment panel III criteria in identifying insulin resistance with dyslipidemia. Diabetes Care 2004;27:978-983 (Pubitemid 38420225)
3. Kawakami A, Aikawa M, Libby P, Alcaide P, Luscinskas FW, Sacks FM. Apolipoprotein CIII inapolipoprotein B lipoproteins enhances the adhesion of human monocytic cells to endothelial cells. Circulation 2006;113:691-700
4. Kawakami A, Osaka M, Aikawa M, et al. Toll-like receptor 2mediates apolipoprotein CIII-induced monocyte activation. Circ Res 2008;103:1402-1409
5. Navab M, Hough GP, Berliner JA, et al. Rabbit beta-migrating very low density lipoprotein increases endothelial macromolecular transport without altering electrical resistance. J Clin Invest 1986;78:389-397 (Pubitemid 16074075)
6. Ai M, Otokozawa S, Asztalos BF, et al. Small dense LDL cholesterol and coronary heart disease: results from the Framingham Offspring Study. Clin Chem 2010;56:967-976
7. Mora S, Otvos JD, Rosenson RS, Pradhan A, Buring JE, Ridker PM. Lipoprotein particle size and concentration by nuclear magnetic resonance and incident type 2 diabetes in women. Diabetes 2010;59:1153-1160
8. Chen CH, Jiang T, Yang JH, et al. Low-density lipoprotein inhypercholesterolemic human plasma induces vascular endothelial cell apoptosis by inhibiting fibroblast growth factor 2 transcription. Circulation 2003;107:2102-2108 (Pubitemid 36532191)
9. Yang CY, Raya JL, Chen HH, et al. Isolation, characterization, and functional assessment of oxidatively modified subfractions of circulating low-density lipoproteins. Arterioscler Thromb Vasc Biol 2003;23:1083-1090 (Pubitemid 36713565)
10. Bancells C, Benitez S, Ordonez-Llanos J, et al. Immunochemical analysis of the electronegative LDL subfraction shows that abnormal N-terminal apolipoprotein B conformation is involved in increased binding to proteoglycans. J Biol Chem 2011;286:1125-1133
11. Bancells C, Villegas S, Blanco FJ, et al. Aggregated electronegative low density lipoprotein in human plasma shows a high tendency toward phospholipolysis and particle fusion. J Biol Chem 2010;285:32425-32435
12. Mello AP, da Silva IT, Abdalla DS, Damasceno NR. Electronegative low-density lipoprotein: origin and impact on health and disease. Atherosclerosis 2011;215:257-265
13. Lu J, Jiang W, Yang JH, et al. Electronegative LDL impairs vascular endothelial cell integrity in diabetes by disrupting fibroblast growth factor 2 (FGF2) autoregulation. Diabetes 2008;57:158-166
14. Tang D, Lu J, Walterscheid JP, et al. Electronegative LDL circulating insmokers impairs endothelial progenitor cell differentiation by inhibiting Akt phosphorylation via LOX-1. J Lipid Res 2008;49:33-47
15. Lu J, Yang JH, Burns AR, et al. Mediation of electronegative low-density lipoprotein signaling by LOX-1: a possible mechanism of endothelial apoptosis. Circ Res 2009;104:619-627
16. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001;285:2486-2497
17. Striekland DK, Ashcom JD, Williams S, et al. Primary structure of alpha 2-macroglobulin receptor-associated protein. Human homologue of a Heymann nephritis antigen. J Biol Chem 1991;266:13364-13369 (Pubitemid 21907353)
18. Oda E. Metabolic syndrome: its history, mechanisms, and limitations. Acta Diabetol 2011;48:79-88
19. Reaven GM. The metabolic syndrome: time to get off the merry-go-round? J Intern Med 2011;269:127-136
20. Catapano AL, Jackson RL, Gilliam EB, Gotto AM Jr, Smith LC. Quantification of apoC-II and apoC-III of human very low density lipoproteins by analytical isoelectric focusing. J Lipid Res 1978;19:1047-1052 (Pubitemid 9059817)
21. Ruby MA, Goldenson B, Orasanu G, Johnston TP, Plutzky J, Krauss RM. VLDL hydrolysis byLPL activates PPAR-alpha through generation of unbound fatty acids. J Lipid Res 2010;51:2275-2281
22. Reinbold M, Hufnagel B, Kewitz T, Klumpp S, Krieglstein J. Unsaturated fatty acids liberated from VLDL cause apoptosis in endothelial cells. Mol Nutr Food Res 2008;52:581-588
23. Marathe GK, Silva AR, de Castro Faria Neto HC, et al. Lysophosphatidylcholine and lyso-PAF display PAF-like activity derived from contaminating phospholipids. J Lipid Res 2001;42:1430-1437 (Pubitemid 34007673)
24. Park K, Gross M, Lee DH, et al. Oxidative stress and insulin resistance: the coronary artery risk development in young adults study. Diabetes Care 2009;32:1302-1307